Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06337721 · ClinicalTrials.gov registry record · NA
Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults
A NA study, sponsored by University of California, Riverside.
- Not yet
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT06337721: Clinical Trial NA study, sponsored by University of California, Riverside.
NCT06337721 is a NA study that has not yet begun recruiting, run by University of California, Riverside. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06337721, a NA study, has not yet begun recruiting, sponsored by University of California, Riverside.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study will: (1) refine and finalize the SPEAR intervention manual for preventing alcohol use disorders (AUD) and associated harms for Pacific Islander young adults; and (2) test SPEAR for efficacy by conducting a pretest-posttest randomized controlled trial (RCT).
Primary Outcome
\# of Days of HED out of past 30 days
Interventions
- BEHAVIORAL SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-09 |
| Est. Completion | 2028-08 |
| Phase | NA |
What is known before NCT06337721 opens enrollment
NCT06337721 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction) is the first listed.
NCT06337721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06337721 about?
NCT06337721 is a clinical study titled "Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults". This study will: (1) refine and finalize the SPEAR intervention manual for preventing alcohol use disorders (AUD) and associated harms for Pacific Islander young adults; and (2) test SPEAR for efficacy by conducting a pretest-posttest randomized controlled trial (RCT).
What is the current status of trial NCT06337721?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2024-09. Estimated completion is 2028-08.
What interventions are being tested in trial NCT06337721?
The interventions under investigation include: SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06337721?
This trial is sponsored by University of California, Riverside, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06337721's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia